Researchers Decode Toxoplasmosis’ Control of Immune Cells
By LabMedica International staff writers Posted on 20 Dec 2017 |
Image: A photomicrograph of a dendritic cell (green) infected by Toxoplasma gondii (red) (Photo courtesy of The Wenner-Gren Institute).
The infection toxoplasmosis is caused by the parasite Toxoplasma gondii and is widely spread. It is estimated that 30%-50% of the global human population are carriers. Cats are the parasites' main host, but the infection is also spread among other animals, including humans.
Toxoplasmosis is life-threatening to people with impaired immune systems and to unborn fetuses, but causes only mild symptoms in healthy individuals. However, there are studies showing that mental illnesses such as schizophrenia, depression and anxiety disorder are more common in people who are carriers of T. gondii.
Scientists collaborating with those at Stockholm University (Stockholm, Sweden) have shown how an obligate intracellular pathogen, T. gondii, takes advantage of a hitherto uncharacterized Ca2+ signaling axis in dendritic cells (DCs) to modulate the migration of parasitized host cells. They have demonstrated that the hypermigratory phenotype induced in DCs by T. gondii is predominantly dependent on the L-type voltage-dependent Ca2+ channel (VDCC) subtype Cav1.3, which is activated by γ-Aminobutyric acid (GABAergic) signaling upon T. gondii invasion.
The team found that by silencing of Cav1.3 by short hairpin RNA or selective pharmacological antagonism of VDCCs abolished the Toxoplasma-induced hypermigratory phenotype. In a mouse model of toxoplasmosis, VDCC inhibition of adoptively transferred Toxoplasma-infected DCs delayed the appearance of cell-associated parasites in the blood circulation and reduced parasite dissemination to target organs. The findings define a novel motility-related signaling axis in DCs and unveil those interneurons and DCs share common GABAergic motogenic pathways. T. gondii employs GABAergic non-canonical pathways to induce host cell migration and facilitate dissemination.
Antonio Barragan, PhD, a professor and the senior author of the study said, “We have decoded how the parasite takes control of immune cells, converting them into moving "zombies" which spread the parasite in the body. This helps us understand how the parasite is spread and disease occurs. In the longer term, it may help us develop targeted treatments for infection.” The study was published on December 7, 2017, in the journal Public Library of Science Pathogens.
Related Links:
Stockholm University
Toxoplasmosis is life-threatening to people with impaired immune systems and to unborn fetuses, but causes only mild symptoms in healthy individuals. However, there are studies showing that mental illnesses such as schizophrenia, depression and anxiety disorder are more common in people who are carriers of T. gondii.
Scientists collaborating with those at Stockholm University (Stockholm, Sweden) have shown how an obligate intracellular pathogen, T. gondii, takes advantage of a hitherto uncharacterized Ca2+ signaling axis in dendritic cells (DCs) to modulate the migration of parasitized host cells. They have demonstrated that the hypermigratory phenotype induced in DCs by T. gondii is predominantly dependent on the L-type voltage-dependent Ca2+ channel (VDCC) subtype Cav1.3, which is activated by γ-Aminobutyric acid (GABAergic) signaling upon T. gondii invasion.
The team found that by silencing of Cav1.3 by short hairpin RNA or selective pharmacological antagonism of VDCCs abolished the Toxoplasma-induced hypermigratory phenotype. In a mouse model of toxoplasmosis, VDCC inhibition of adoptively transferred Toxoplasma-infected DCs delayed the appearance of cell-associated parasites in the blood circulation and reduced parasite dissemination to target organs. The findings define a novel motility-related signaling axis in DCs and unveil those interneurons and DCs share common GABAergic motogenic pathways. T. gondii employs GABAergic non-canonical pathways to induce host cell migration and facilitate dissemination.
Antonio Barragan, PhD, a professor and the senior author of the study said, “We have decoded how the parasite takes control of immune cells, converting them into moving "zombies" which spread the parasite in the body. This helps us understand how the parasite is spread and disease occurs. In the longer term, it may help us develop targeted treatments for infection.” The study was published on December 7, 2017, in the journal Public Library of Science Pathogens.
Related Links:
Stockholm University
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia